REFERENCES
- Markowits G.S., Kahn G.E., Feingold R.E. An Evaluation of the Effectiveness of Oral Iron Therapy in Hemodialysis Patients Receiving Recombinant Human Erythropoietin. Clin. Nephrol. 1997; 48: 34–40
- NKF Anemia Work Group. NKF–DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am. J. Kidney Dis. 1997; 30(Supp. 3)192–240
- MacDougall I.C., Tucker B., Thompson J. A Randomized Controlled Study of Iron Supplementation in Patients Treated with Erythropoietin. Kidney Int. 1996; 50: 1694–1699
- Fishbane S., Frei G.L., Maesaka J. Reduction in Recombinant Human Erythropoietin Doses by the Use of Chronic Intravenous Iron Supplementation. Am. J. Kidney Dis. 1995; 26: 41–46
- Kurihara I., Saito T., Nakayama K. Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin. Nephron. 1998; 80: 369–370